Quantitative real-time reverse transcription: Polymerase chain reaction of prostate-specific antigen (PSA) for detection of circulating prostatic cells in patients with clinically localized prostate cancer

Prostate Cancer and Prostatic Diseases

Volumn 8, Issue 3, 2005, Pages 248-252

  Llanes, L ^a   Ferruelo, A ^a   Lujan M ^a   Pascual, C ^a   Garcia Mediero J M ^a   Berenguer, A ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

Prostate specific antigen; Prostatic neoplasm; Reverse transciptase polymerase chain reaction

Indexed keywords

MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; GENE EXPRESSION; GLEASON SCORE; HUMAN; MALE; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUANTITATIVE DIAGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR BIOPSY;

AGED; AREA UNDER CURVE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, RIBOSOMAL, 18S; ROC CURVE;

EID: 31044443907     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500801     Document Type: Article

References (31)

1. Epstein JI. Incidence and significance of positive margins in radical prostatectomy specimens. Urol Clin North Am 1996; 23: 651-663.
2. Moreno JG et al. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res 1992; 52: 6110-6112.
3. Vesella RL et al. A sensitive method for detection of a prostate tumor cell marker using the PCR. J Urol 1992; 147: 441A.
4. Israeli RS et al. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific antigen and prostate-specific membrane antigen-based assays. Cancer Res 1994; 54: 6306-6310.
5. Corey E et al. Detection of circulating prostate cells by reverse transcriptase polymerase chain reaction (RT-PCR) of human glandular kallikrein (hK2) and prostate specific antigen (PSA) messages. Urology 1997; 50: 184-188.
6. Kawakami M et al. Detection of prostate cancer cells circulation in peripheral blood by reverse transcription-PCR for hKLK2. Cancer Res 1997; 57: 4167-4170.
7. Partin AW et al. Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millenium. Urology 2001; 58: 843-848.
8. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M (eds). AJCC Cancer Staging Manual, 6th ed., Springer-Verlag: New York, 2002, ISBN: 0-387-95271-3.
9. User Bulletin #2 ABI PRISM 7700 Sequence Detection System. Applied Biosystem: Madrid, Spain. December 11, 1997 (updated 10/2001).
10. Katz EA et al. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology 1994; 43: 765-775.
11. Katz AE et al. Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer 1995; 75: 1642-1648.
12. Okegawa T et al. Molecular staging of prostate cancer: Comparison of nested reverse transcription polymerase chain reaction assay using prostate-specific antigen versus prostate-specific membrane antigen as primer. Int J Urol 1998; 5: 349-356.
13. Okegawa T et al. Value of reverse transcription polymerase chain reaction assay in pathological stage T3N0 prostate cancer. Prostate 2000; 44: 210-218.
14. Zhang Y et al. Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells. Clin Cancer Res 1997; 3: 1215-1220.
15. Israeli RS et al. Sensitive detection of prostatic hematogenous micrometastases using PSA and PSM-derived primers in the polymerase chain reaction. J Urol 1995; 153: 573-577.
16. Grasso YZ et al. Combined nested RT-PCR assay for PSA and PSMA in prostate cancer patients: Correlation with pathological stage. Cancer Res 1998; 58: 1456-1459.
17. Melchior SW et al. Early tumor cell disemination in patients with clinically localized carcinoma of the prostate. Clin Cancer Res 1997; 3: 249-256.
18. Corey E, Corey MJ. Detection of disseminated prostate cells by reverse transcription-polymerase chain reaction (RT-PCR): Technical and clinical aspects. Int J Cancer 1998; 77: 655-673.
19. Llanes L et al. Detecting circulating prostate cells in patients with clinically localized prostate cancer: Clinical implications for molecular staging. Br J Urol Int 2000; 86: 1023-1027.
20. Lintula S, Stenman UH. The expression of prostate specific membrane antigen in peripheral blood leukocytes. J Urol 1997; 157: 1969-1972.
21. Llanes L et al. The clinical utility of the prostate specific membrane antigen reverse-transcription/polymerase chain reaction to detect circulating prostate cells: An analysis in healthy men and women. Br J Urol Int 2002; 89: 882-885.
22. Smith MR, Biggar S, Hussain M. Prostate-specific antigen messenger RNA is expressed in non-prostate cells: Implications for detection of micrometastases. Cancer Res 1995; 55: 2640.
23. Zippelius A et al. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol 1997; 15: 2701-2708.
24. Gomella LG et al. Quantitation of the circulating hematogenous tumor cell load in prostate cancer. J Urol 1999; 161 (Suppl): 368A.
25. Ylikoski A et al. Simultaneous quantification of human glandular kallikrein 2 and prostate-specific antigen mRNAs in peripheral blood from prostate cancer patients. J Mol Diagn 2001; 3: 111-122.
26. Sokoloff MH et al. Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: A clinicopathological molecular analysis of 121 patients. J Urol 1996; 156: 1560-1566.
27. Haese A et al. Quantitative reverse-transcriptase polymerase chain reaction for the detection of PSA mRNA before and after radical prostatectomy. J Urol 1999; 161 (Suppl): 953A.
28. Straub B et al. Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and transurethral resection of the prostate using 'Light-Cycler'-based quantitative real-time polymerase chain reaction. Urology 2001; 58: 815-820.
29. Straub B et al. Quantitative real-time rt-PCR for detection of circulating prostate-specific antigen mRNA using sequence-specific oligonucleotide hybridization probes in prostate cancer patients. Oncology 2003; 65 (Suppl 1): 12-17.
30. Gelmini S et al. Real-time RT-PCR for the measurement of prostate-specific antigen mRNA expression in benign hyperplasia and adenocarcinoma of prostate. Clin Chem Lab Med 2003; 41: 261-265.
31. O'Hara SM et al. Multigene reverse transcription-PCR profiling of circulating tumor cells in hormone-refractory prostate cancer. Clin Chem 2004; 50: 826-835.